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20 Background: Personalised nutrition (PN) may promote public health. PN involves dietary advice based on
individual characteristics of end users and can for example be based on lifestyle, blood and/or DNA profiling.
Currently, PN is not refunded by most health insurance or health care plans. Improved public health is contingent
on individual consumers being willing to pay for the service.Methods: A survey with a representative sample from
the general population was conducted in eight European countries (N = 8233). Participants reported their will-
25 ingness to pay (WTP) for PN based on lifestyle information, lifestyle and blood information, and lifestyle and DNA
information. WTP was elicited by contingent valuation with the price of a standard, non-PN advice used as
reference. Results: About 30% of participants reported being willing to pay more for PN than for non-PN
advice. They were on average prepared to pay about 150% of the reference price of a standard, non-personalised
advice, with some differences related to socio-demographic factors. Conclusion: There is a potential market for PN
30 compared to non-PN advice, particularly among men on higher incomes. These findings raise questions to what
extent personalized nutrition can be left to the market or should be incorporated into public health programs.
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Introduction
Balanced nutrition is of paramount importance to public health.35 Today’s foods are abundant and generally safe and of high
quality. Nutrition does however also have more long term public
health effects that tend to differ between individuals and countries in
Europe.1 Nutrition has different effects on individuals and food
choices made in early life may impact health and quality of life
40 decades from now.2 With the ageing population and the growing
impact of non-communicable health problems, long-term effects of
healthier nutrition may have relevantly influence public health. Such
long-term effects of nutrition that contribute to healthy ageing may
differ between individuals. Potential public health improvement can
45 only be achieved if individuals receive advice tailored to their
personal nutritional needs, and if subsequently make the right
food choices for their individual situation Current advances in
nutrition science and more specifically in nutrigenomics indicate
that more specific information about an individual could be used
50 to develop personalised nutrition (PN) advice that is tailored to
individual needs.3 Increased personalisation requires more informa-
tion about an individual, e.g. a blood sample to assess cholesterol
levels, in order to suggest specific dietary recommendations. Genetic
analysis can be applied to predict potential future nutritional needs,
55 or to investigate how specific nutrients contribute to the healthiness
of an individual’s diet. PN advice is not only aimed at people that are
already unhealthy or overweight. PN advice can contribute greatly to
the prevention of health problems and even improve current health
if no obvious health problems occur by providing suggestion for
60 change in dietary behaviour based on nutritional needs of these
individuals. Large scale adoption of PN advice by individuals can
improve immediate and long term public health.
Nutrition advice aimed at curing nutrition related diseases is
covered by most public health and health insurance systems.
65 Currently, most health insurance companies or health service
providers, such as the UK NHS, or health care insurances in the
Netherlands or Germany do not refund the cost of PN advice. PN
advice is considered a preventive or health enhancement advice
which at this moment in time is generally placed outside health
70care systems. Community support to high-risk populations is
sometimes included, such as in diabetes prevention programs in
the US;4 but individuals who are not part of a vulnerable group or
patients are generally expected to organise nutrition advice
themselves. Therefore, in the short term, adoption of PN depends
75on consumers’ willingness to pay (WTP) for commercial PN advice.
Various businesses across Europe have marketed PN as a viable op-
portunity, using a range of personalisation techniques and business
models.5 The failure rate of these companies is however high, which
may in part be because listed prices are more based on the incurred
80cost of more advanced personalisation methods than on a clear idea
about how much consumers are willing to spend on PN advice at
different levels of personalisation.6 Reasons why consumers may not
be willing to pay more for PN advice requiring DNA or blood testing
may be that consumers see potential privacy risks, or do not believe
85these additional, costly analyses will result in better advice.6
This article presents results from a survey that assessed people’s
WTP for PN based on three different levels of personal information:
(i) lifestyle (food consumption and physical exercise pattern); (ii)
lifestyle and phenotype (from analysis of a blood sample); lifestyle
90and genotype (from DNA testing using a saliva sample). To identify
potential groups most likely to adopt PN advice, comparisons
regarding WTP were made between countries, gender, age groups
and income and education levels.
Methods
95A survey was conducted in November and December 2012 with
participants from eight EU countries (Greece, Spain, Germany,
Ireland, Netherlands, UK. Poland and Norway.). Samples were
representative on gender, age and education level for the general
population in their country and participants were members of
existing panels of consumer research agencies who consented in
receiving survey invitations. Data collection was part of a larger
5 study on PN where more details about the procedure can be
found.7 Data reported here have not been published previously.
WTP was measured as a two-step contingent valuation.
Participants were first asked whether they would be willing to pay
a price equal to that of standard, non-PN advice provided by a
10 qualified dietitian. Those who reported a WTP of at least this
reference price were provided with a continuous scale of which
the lower end represented the reference price, and the higher end
being five times the reference price. Participants who reported to be
not willing to pay the reference price were provided with a scale that
15 ranged from 0 to the reference price.
Based on an internet survey on the price of general dietary advices
consisting of one intake session and a three month follow up advice
in the Netherlands the reference price for PN was estimated at about
100E, which was then translated to reference prices for all
20 participating countries using the Eurostat Comparative Price Level
index of 2011.8 To check whether the calculated reference prices
resembled dietary advice prices of the participating countries, the
reference price of each country was compared to the price of a
national Weight Watchers (Weight Watchers is an international
25 company that offers various products and services to assist weight
loss and maintenance.) dietary service. To allow comparability
across countries, the reported WTPs were expressed as percentages
of the reference prices. Each participant scored WTP for nutrition
advice based on three, increasingly personal, levels of personal in-
30 formation: lifestyle (about daily diets and exercise); lifestyle and
phenotype (with additional information from blood chemistry in-
formation); and, lifestyle and genotype (with additional information
from DNA testing using a saliva sample). The order of WTP scoring
was randomized.
35 WTP data were coded into three classes: (1) Nothing: Participants
reporting a WTP below 1% of the reference (2) Low: Participants
reporting a WTP below reference, but more than 0; (3) High:
Participants reporting WTP higher than the reference price. In
addition, age, gender, income [compared to the modal income of
40 country of residence (Modal incomes at the time of data collection
were: Germany: 25 000E; Spain: 22 000E; Greece: 20 000E; Ireland:
24 000E; Netherlands: 30 000E; United Kingdom: 22 000£; Poland:
50,000 Zloty; Norway: 322 000 kroner, Portuguese participants did
not fill out this question.)], education (Low: 12 or fewer years of
45 schooling, including kindergarten; Medium: 12–16 years education;
High: degree level) were recorded. Of the 8233 participants, 919 did
not disclose income. These participants were omitted from analyses
that included income as determinant. Distributions of participants
across the WTP classes were cross-tabulated and tested using 2. In
50 addition, factorial ANOVAs were conducted testing the main effects
of the sociodemographic on WTP, for the Lower and Higher WTP
class (For the Nothing WTP class, an ANOVA would be meaningless
since all participants in this class scored a WTP equal to 0) and each
level of personal information.
55
Results
Sample description
A total of 8233 participants from the representative survey
completed the questionnaire. Gender distribution was about equal
(50.6% male). Twenty-two percent of participants were aged
60between 18 and 29 years; 23% between 30 and 39 years; 35%
between 40 and 54 years; and 20% between 55 and 65 years.
Twenty-nine percent reported low education level; 39% had
completed medium level education; and, 32% had completed
higher education. Income distribution peaked (as expected)
65around the modal income of each country, with 49.3% (3605) of
those willing to disclose income information, earning between 0.5
and 1.5 times modal income.
General results
Average WTP as percentage of the reference price provided is
70reported in Table 1.
A minority of the participants (about 30% see Table 2) showed
a high WTP for PN advice. About half showed a low WTP. The
remaining participants (about 20%; Table 2) reported not being
willing to pay anything for PN advice. These percentages differed
75between the three levels of information (Friedman 2(2) = 106.98,
N = 8233, P < 0.001). For lifestyle-based nutrition advice,
relatively fewer participants had a WTP above the reference
price and more a WTP below the reference price. For lifestyle
and phenotype information, more participants were willing to
80pay more, and fewer did not want to pay anything. For lifestyle
and phenotype analysis and lifestyle and genotype analysis,
relatively many participants were willing to pay nothing, while
relatively few participants were willing to pay a lower than
reference price (Table 2).
Table 1 Average WTP per country per type of required personal information
Country N Reference price
(local currency)
Average in % reference
Lifestyle Lifestyle +
Phenotype
Lifestyle +
Genotype
Greece 1020 90E 70.24 75.81 76.64
Spain 1025 90E 65.84 68.77 71.21
Germany 1020 100E 53.38 54.32 54.62
Ireland 1020 110E 68.42 69.64 68.44
Netherlands 1020 100E 42.35 41.70 41.26
UK 1061 £80 44.24 47.53 46.65
Poland 1045 230 Zloty 64.50 68.67 70.99
Norway 1022 1100 Norse kroner 52.15 57.23 54.90
Table 2 Distribution of WTP (as percentage of reference price) per
personalisation level
Lifestyle Lifestyle + phenotype Lifestyle + genotype
N 8233 8233 8233
Nothing 19.6% 19.1% 20.8%
Lower 51.5% 49.9% 48.4%
Mean (SD) 30.10 (21.40) 30.44 (21.66) 30.68 (21.83)
Median 25.56 26.10 27.27
Higher 29.0% 31.0% 30.7%
Mean (SD) 143.84 (62.53) 143.27 (61.14) 146.73 (63.64)
Median 120.00 119.00 122.23
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Demographic differences
The effects of gender, age, income, education level and country
showed several statistically significant differences in WTP class and
mean WTP within the WTP class (Table 3 shows statistical tests;
5Figure 1 shows distribution and means).
Discussion
About a third of the participants reported WTP for PN higher than
the reference price of standard, non-PN advice. Those participants
were on average willing to pay a price of 40% and 50% of higher
10than the reference price. The additional price people were willing to
pay for the more advanced forms (blood or DNA sample based) of
personalisation (based on phenotype or genotype) was very small
compared to what participants were willing to pay for lifestyle-only
based PN advice. This aligns with previous research,9 where it was
15reported that people did not perceive additional benefits accruing
from more medicalised personal data and suggests such advanced
methods should be developed at little extra cost.
A sizable minority (20%) indicated that they are willing to pay
nothing for PN, and about half of all participants indicated WTP for
20PN lower than for standard nutrition advice. While this may imply
these participants reject the idea of PN altogether this is not neces-
sarily the case. Current concerns about inadequate procedure to
guarantee data privacy, lack of confidence in the efficacy of PN, or
distrust in commercial service providers9 may have reduced WTP
25regardless of perceived acceptance of PN per se. Another group may
have consisted of people who were potentially interested in adopting
a PN advice but were opposed to paying for healthcare from their
private funds because this is seen as a responsibility of the state.11
There may have been a group of people for whom the personalized
30nutrition remained abstract and hypothetical and therefore indicated
a low WTP, this may be particularly the case for a group of people
not willing to pay for any nutrition service which may have reduced
WTP for PN services (A much larger proportion (about 60%) of
participants in a proof of principle trial in the same countries
35completed the same survey (7) and were willing to pay a higher
price for a PN service than for a non-PN service (data not
shown), indicating that motivation to engage with nutrition advice
may be a central driver for adoption.)10. This relates to another
potential limitation to the current study that in the used
40contingent valuation method participants did not make any actual
monetary sacrifice.13 Future research is needed to investigate the
reasons why WTP is so low, and under what conditions these
people would participate in a PN program.
Analysis of differences based on demographic variables gives some
45insights into what participants are most likely to adopt a PN advice.
There were some differences in WTP between countries. Participants
from the Netherlands and the UK most often reported they did not
want to pay anything or at least less than the reference. Participants
in these countries either wanted to pay the least, but those with WTP
50more than the reference price were among those with the highest
WTP. This may have to do with the availability of relatively inex-
pensive basic healthcare (Netherlands), or free of direct charge basic
healthcare (UK), while additional, non-standard care is something
for which inhabitants of these countries are accustomed to pay when
55they use it.
There were more males than females reporting a WTP of nothing.
Males with low WTP reported lower WTP than female participants,
males with a WTP higher than the reference value had a higher WTP
than females. This suggests that male participants, once committed
60to pay more or less for PN than conventional nutrition advice, are
more extreme in their deviation from standard nutrition advice
WTP than females.
Participants in the highest income classes reported the highest
WTP for PN. This suggests that commercial introduction of
65personalized nutrition services would benefit higher socioeconomicT
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classes most, while it is generally accepted that these groups in the
population already have better health.12 The higher WTP may in
part be related to higher income classes having more awareness of
health issues, but it may also relate to the availability of resources
5 (money) to purchase nutrition services. This suggests that if avail-
ability of PN advice is regulated by commercial markets, these may
explicitly target the higher social classes and incomes to maximize
profit; while PN advice to these population groups may have the
least positive effect on public health. This raises important ethical
10questions to whether PN should also be accessible to lower income
classes that may need it more than those with high income.
Considering the low WTP of these income classes alternatives to
commercial businesses seem more promising ways to have these
groups benefit from PN advice for example PN advice provided
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Figure 1 WTP for different levels of PN by (a) Country (b) Gender (c) Income (d) Age and (e) Education. Bars indicate proportion of
participants willing to pay: Nothing (dark grey), Lower than reference (mid grey) and Higher than reference (light grey). Lines and numbers
indicate mean WTP in percentage of the reference
4 of 5 European Journal of Public Health
through employers or insurance companies. Alternatively, a hybrid
form of commercial and public services could be considered, where
basic PN services is covered by a national health program, while
specific implementations such as comprehensive lifestyle advice
5 and applications to monitor progress6 may be left to the market.
The answer to this issue is beyond the scope of the current paper,
and should be taken up at the level of policy discussion.
About one third of the population reports to be willing to pay more
for PN than for a conventional nutrition service. This suggests that
10 there may be a market for PN if it can be offered at no more than one
and a half time the price of current nutrition advice services. While
this suggests that PN may find a place in the European population if it
is made available at limited additional cost compared to non-PN
services, it might be more likely to be adopted by those who need it
15 most if it is offered through existing health care systems.
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Key points
 There is a potential market for personalised-nutrition advice
25 in the EU.
 The majority of people is not willing to pay for personalised-
nutrition advice.
 Willingness to pay for personalisation based on DNA
sampling is not higher than for personalisation based on
30 lifestyle or blood data.
 Large scale adoption of PN is likely to require inclusion in
national health services.
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